Chester County News and Community Website
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), headquartered in West Chester, PA, is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. For more information, visit www.verrica.com.
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that Ted White, Verrica President and CEO, will present at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September …
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 24th Annual Global Investment Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) recently announced financial results for the second quarter ended June 30, 2022.
Verrica Pharmaceuticals Reports Second Quarter 2022 Financial Results Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that Torii Pharmaceutical Co., Ltd. recently dosed the first patient in its Phase 3 trial of VP-102 (referred to as …
Verrica Pharmaceuticals Inc. Begins Phase 3 Trial of VP-102 for Molluscum Contagiosum Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) recently announced the pricing of its underwritten public offering of 12,000,000 shares of its common stock at a price to the …
Verrica Announces Pricing of Public Offering of Common Stock Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) recently announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten …
Verrica Announces Proposed Public Offering of Common Stock Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that the Company held a Type A meeting with the U.S. Food and Drug Administration (FDA) on June 27, 2022, …
Verrica Pharmaceuticals Holds Type A Meeting with FDA for VP-102 for Molluscum Contagiosum Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA) announced that the U.S. Food and Drug Administration (FDA) this week issued a Complete Response Letter (CRL) regarding its New …
Verrica Receives Complete Response Letter from the FDA Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA) announced financial results for the first quarter ended March 31, 2022.
Verrica Pharmaceuticals Reports First Quarter 2022 Financial Results Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that Ted White, Verrica President and CEO, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare …
Verrica Pharmaceuticals Announces Participation in the 21st Annual Needham Virtual Healthcare Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) recently announced financial results for the fourth quarter and year ended December 31, 2021.
Verrica Pharmaceuticals Reports Fourth Quarter, Full-Year 2021 Financial Results Read More